Guardant Health
GH
#1670
Rank
NZ$21.33 B
Marketcap
NZ$164.24
Share price
-7.34%
Change (1 day)
96.31%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): NZ-$5.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.36. In 2024 the company made an earnings per share (EPS) of NZ-$5.94 an increase over its 2023 EPS that were of NZ-$7.15.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$5.54-6.74%
2024NZ-$5.94-16.82%
2023NZ-$7.15-33.13%
2022NZ-$10.6960%
2021NZ-$6.6855.04%
2020NZ-$4.31207.14%
2019NZ-$1.40-19.81%
2018NZ-$1.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$4.63-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$3.57-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA